A randomised, parallel-group, double-blind, placebo-controlled study of DPK-060 to investigate clinical safety and efficacy in patients with acute external otitis

Trial Profile

A randomised, parallel-group, double-blind, placebo-controlled study of DPK-060 to investigate clinical safety and efficacy in patients with acute external otitis

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Apr 2013

At a glance

  • Drugs DPK 060 (Primary)
  • Indications Otitis externa
  • Focus Adverse reactions
  • Sponsors DermaGen
  • Most Recent Events

    • 21 Dec 2012 Status changed from recruiting to completed based on information reported in a Pergamum AB media release.
    • 21 Dec 2012 The primary endpoint of drug safety and tolerability was met according to a Pergamum AB media release.
    • 03 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top